Jiangsu Zhongtian Technology Co Ltd (600522)
Shanghai Stock Exchange · China · prices in CNY · close of 19 Oct 2026
Key indicators
| Last close | CNY 28.06 |
|---|---|
| 52-week range | 15.38 – 68.10 |
| Return, 1 month / 3 months | −15.7% / −34.1% |
| Return, 1 year / 3 years | +54.2% / +100.4% |
| Trend | Below its 200-day average |
| RSI (14) | 36 |
| Volatility (1 year) | 66.4% |
| Worst drawdown (1 year) | -61.2% |
| Average daily value traded | 6,999.70M CNY |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Jiangsu Zhongtian Technology, often called ZTT, is a Chinese manufacturer based in Nantong in Jiangsu province. It makes optical fibre and optical cables for telecommunications networks, and it also produces power cables, including submarine cables used in offshore wind and marine projects. The company supplies equipment and engineering services for marine operations, and its customers include telecom operators, power utilities and energy infrastructure developers in China and other markets.
The shares are listed on the Shanghai Stock Exchange in China under the code 600522, and the price on this page is in Chinese yuan (CNY). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Jiangsu Zhongtian Technology Co Ltd (600522) trades on the Shanghai Stock Exchange in China. It last closed at CNY 28.06 on 19 October 2026.
Its price-based Market X-Ray is 47 out of 100 (a weak price profile), ranking 1,253 of 2,278 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 54.2% and over the last three months it fell 34.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Shanghai Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 43 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -15.1% | ||
| From 52-week high | -58.8% | ||
| Momentum | 58 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -34.1% | ||
| 6-month return | -5.8% | ||
| 12-month return, skipping the last month | 83.0% | ||
| Stability (higher is calmer) | 11 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 66.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -61.2% | ||
| Liquidity | 100 · Strong | Trades actively. | |
| Average daily value traded | 6,999.70M CNY | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −1.8% |
|---|---|
| 1 month | −15.7% |
| 3 months | −34.1% |
| 6 months | −5.8% |
| 1 year | +54.2% |
| 3 years | +100.4% |
| 5 years | – |
Signals
| 50-day / 200-day average | 32.79 / 33.06 |
|---|---|
| Golden / death cross (60 days) | Death, 3 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.63 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 4 Aug 2023 | CNY 0.1000 |
| 5 Aug 2022 | CNY 0.1000 |
| 10 May 2021 | CNY 0.1000 |
| 16 Jul 2020 | CNY 0.1000 |
| 16 Jul 2019 | CNY 0.1000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Shanghai Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.